Drug intelligence / Profile preview

EleCeed

Development stage
Unknown
Lead developer
Colcare Laboratories
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

**EleCeed** is a Columbia Care-developed, full-spectrum medical cannabis oral tablet containing equal quantities of delta-9-tetrahydrocannabinol and cannabidiol, plus 10 additional precisely formulated secondary cannabinoids. The patent-pending, pre-scored hard-pressed tablets were introduced as a long-lasting, precisely dosed product for medical-cannabis patients in New York. Delta-9-tetrahydrocannabinol principally activates cannabinoid receptors, while cannabidiol and the broader cannabinoid mixture may modulate cannabinoid signaling and other biological pathways. EleCeed was positioned for symptom management in chronic pain, neuropathy, epilepsy, multiple sclerosis, Parkinson's disease, rheumatoid arthritis, and Crohn's disease.

Brand names
EleCeed
Other names
Eleceed
02

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on EleCeed.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EleCeed.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call